UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biological Relevance of Inflammation and Oxidative Stress in the Pathogenesis of Arterial Diseases

The American journal of pathology, 2013-05, Vol.182 (5), p.1474-1481

2013

Volltextzugriff (PDF)

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

The Lancet (British edition), 2009-04, Vol.373 (9670), p.1175-1182

2009

Volltextzugriff (PDF)

Atherosclerosis risk classification with computed tomography angiography: A radiologic-pathologic validation study

Atherosclerosis, 2023-02, Vol.366, p.42-48

2023

Volltextzugriff (PDF)

Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease: A Meta-Analysis

Journal of the American College of Cardiology, 2013-12, Vol.62 (22), p.2090-2099

2013

Volltextzugriff (PDF)

Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets

The American journal of cardiology, 2012-07, Vol.110 (1), p.3A-14A

2012

Volltextzugriff (PDF)

Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events: A Meta-Analysis of Statin Trials

Journal of the American College of Cardiology, 2014-08, Vol.64 (5), p.485-494

2014

Volltextzugriff (PDF)

Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

The American journal of cardiology, 2014, Vol.113 (1), p.76-83

2014

Volltextzugriff (PDF)

Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health

The American journal of pathology, 2019-03, Vol.189 (3), p.492-501

2019

Volltextzugriff (PDF)

Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.717-724

2004

Volltextzugriff (PDF)

Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials

Pharmacological research, 2018-06, Vol.132, p.232-241

2018

Volltextzugriff (PDF)

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

The Lancet (British edition), 2010-07, Vol.376 (9738), p.333-339

2010

Volltextzugriff (PDF)

Recent Clinical Studies of the Effects of Lipid-Modifying Therapies

The American journal of cardiology, 2012-07, Vol.110 (1), p.15A-26A

2012

Volltextzugriff (PDF)

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association

Journal of clinical lipidology, 2017-07, Vol.11 (4), p.880-890

2017

Volltextzugriff (PDF)

Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials

Journal of clinical lipidology, 2020-09, Vol.14 (5), p.649-659.e6

2020

Volltextzugriff (PDF)

New Insights into the High-Density Lipoprotein Dilemma

Trends in endocrinology and metabolism, 2016-01, Vol.27 (1), p.44-53

2016

Volltextzugriff (PDF)

Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials

Atherosclerosis, 2023-05, Vol.373, p.1-9

2023

Volltextzugriff (PDF)

HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions

Drug discovery today, 2018-01, Vol.23 (1), p.171-180

2018

Volltextzugriff (PDF)

Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins

Journal of clinical lipidology, 2018-07, Vol.12 (4), p.849-856

2018

Volltextzugriff (PDF)

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

The American journal of cardiology, 2004-01, Vol.93 (2), p.136-141

2004

Volltextzugriff (PDF)

The evolving role of statins in the management of atherosclerosis

Journal of the American College of Cardiology, 2000-01, Vol.35 (1), p.1-10

2000

Volltextzugriff (PDF)

A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis

Journal of the American College of Cardiology, 2005-05, Vol.45 (10), p.1611-1619

2005

Volltextzugriff (PDF)

Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy

The American journal of cardiology, 2010-05, Vol.105 (9), p.1289-1296

2010

Volltextzugriff (PDF)

Role of C-Reactive Protein in Coronary Risk Reduction: Focus on Primary Prevention

The American journal of cardiology, 2007-03, Vol.99 (5), p.718-725

Gotto, Antonio M., MD, DPhil

2007

Volltextzugriff (PDF)

High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease

The American heart journal, 2002-12, Vol.144 (6), p.S33-S42

Gotto, Antonio M.

2002

Volltextzugriff (PDF)

Highly conserved amino acid residues in apolipoprotein A1 discordantly induce high density lipoprotein assembly in vitro and in vivo

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020-12, Vol.1865 (12), p.158794-158794, Article 158794

2020

Volltextzugriff (PDF)

1 – 25 von 280

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(264)
Mit Volltextzugriff
(269)

Publikationsform

Sprache

Englisch
(280)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Biological Relevance of Inflammation and Oxidative Stress in the Pathogenesis of Arterial Diseases

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Atherosclerosis risk classification with computed tomography angiography: A radiologic-pathologic validation study

Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease: A Meta-Analysis

Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets

Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events: A Meta-Analysis of Statin Trials

Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health

Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update

Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

Recent Clinical Studies of the Effects of Lipid-Modifying Therapies

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association

Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials

New Insights into the High-Density Lipoprotein Dilemma

Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials

HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions

Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

The evolving role of statins in the management of atherosclerosis

A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis

Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy

Role of C-Reactive Protein in Coronary Risk Reduction: Focus on Primary Prevention

High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease

Highly conserved amino acid residues in apolipoprotein A1 discordantly induce high density lipoprotein assembly in vitro and in vivo

Aktive Filter

Suchergebnisse filtern